C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 277/48 (2006.01) C07D 213/75 (2006.01) C07D 233/88 (2006.01) C07D 241/20 (2006.01) C07D 261/14 (2006.01) C07D 271/08 (2006.01) C07D 277/56 (2006.01) C07D 277/60 (2006.01) C07D 277/82 (2006.01) C07D 285/08 (2006.01) C07D 285/12 (2006.01) C07D 417/04 (2006.01) C07D 417/06 (2006.01) C07D 417/12 (2006.01) C07D 417/14 (2006.01)
Patent
CA 2551324
This invention relates to compounds that are of formula (I) wherein A is heteroaryl and R1 and R2 are both cyclic residues, that are activators of glucokinase and thus may be useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial .
L'invention concerne des composés qui correspondent à la formule (I) dans laquelle A est un hétéroaryle et R?1¿ et R?2¿ sont tous deux des résidus cycliques, qui sont des activateurs de glucokinase et peuvent, de ce fait, s'utiliser pour gérer, traiter ou pour lutter contre des maladies ainsi qu'en tant que traitement auxiliaire lorsque l'augmentation des activités de glucokinase a un effet bénéfique.
Andrews Robert Carl
Ankersen Michael
Christen Daniel P.
Cooper Jeremy T.
Jeppesen Lone
Dimock Stratton Llp
Novo Nordisk A/s
LandOfFree
Heteroaryl-ureas and their use as glucokinase activators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heteroaryl-ureas and their use as glucokinase activators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heteroaryl-ureas and their use as glucokinase activators will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1501154